Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genolar vs Xolair in Persistent Atopic Bronchial Asthma
NCT04607629Phase 3Completed
- Sponsor
- Generium
- Start
- Jun 2018
- Primary completion
- Apr 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of omalizumab, sponsored by Generium. Started Jun 2018; status: completed.
02
Drugs
omalizumab
Beyond the preview
Go deeper on NCT04607629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04607629.